A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients

The Grasses of Eden Ltd550 enrolled

Overview

A Nasal Spray device containing Dead Sea minerals and plant extracts, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients

A Nasal Spray device containing Dead Sea minerals and plant extracts, designed to incur a PPAR-alpha agonistic effect, used to shorten duration and mitigate effects of Covid-19 infection in mild to moderate adult patients

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

550

Conditions

COVID-19 Infection

Interventions

Nasal Spray DeviceDEVICE

A Nasal Spray apparatus containing a liquid

Eligibility

Sex: ALLMin age: 16 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Having tested positive to Covid-19 on PCR test - Exclusion Criteria: Pregnancy Low blood pressure On immune system suppressing medications \-

Outcomes

Primary Outcomes

Covid-19 infection self-testing on days 2, 4 following testing positive on PCR test

Testing using a self testing kit of the Quidel QuickView type

Time frame: First 7 days after testing positive on PCR test

Symptoms monitoring

Monitoring any disease symptoms reported by patient

Time frame: First 7 days after testing positive on PCR test

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.